{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:52:03Z","timestamp":1792792323741,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19808"],"award-info":[{"award-number":["17K19808"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12874-018-0554-2","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:03:49Z","timestamp":1537779829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study"],"prefix":"10.1186","volume":"18","author":[{"given":"Zheng","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-3776","authenticated-orcid":false,"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"8","key":"554_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011623","volume":"6","author":"QH Pu","year":"2016","unstructured":"Pu QH, Lyu QJ, Su HY. Bibliometric analysis of scientific publications in transplantation journals from mainland China, Japan, South Korea and Taiwan between 2006 and 2015. BMJ Open. 2016;6(8):e011623.","journal-title":"BMJ Open"},{"key":"554_CR2","doi-asserted-by":"crossref","unstructured":"Chen K, Yao Q, Sun J, He ZF, Yao L, Liu ZY. International publication trends and collaboration performance of China in healthcare science and services research. Isr J Health Policy Res. 2016;5(1).","DOI":"10.1186\/s13584-016-0061-z"},{"issue":"9","key":"554_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011605","volume":"6","author":"Y Zou","year":"2016","unstructured":"Zou Y, Li Q, Xu W. Scientific research output in orthopaedics from China and other top-ranking countries: a 10-year survey of the literature. BMJ Open. 2016;6(9):e011605.","journal-title":"BMJ Open"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-014-0245-4","volume":"14","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Becker T, Ma Y, Koesters M. A systematic review of Chinese randomized clinical trials of SSRI treatment of depression. BMC Psychiatry. 2014;14:245.","journal-title":"BMC Psychiatry"},{"key":"554_CR5","doi-asserted-by":"crossref","unstructured":"Khanna P, Suo T, Komossa K, Ma H, Rummel-Kluge C, El-Sayeh HG, Leucht S, Xia J. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2014;(1):Cd006569.","DOI":"10.1002\/14651858.CD006569.pub5"},{"key":"554_CR6","first-page":"CD006569","volume":"4","author":"K Komossa","year":"2009","unstructured":"Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, Kissling W, Leucht S. Aripiprazole versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev. 2009;4:CD006569.","journal-title":"Cochrane Database Syst Rev"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13643-015-0017-3","volume":"4","author":"JF Cohen","year":"2015","unstructured":"Cohen JF, Korevaar DA, Wang J, Spijker R, Bossuyt PM. Should we search Chinese biomedical databases when performing systematic reviews? Syst Rev. 2015;4:23.","journal-title":"Syst Rev"},{"key":"554_CR8","unstructured":"Higgins JP, Green S (eds.): Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011] Available from \n                    http:\/\/handbook-5-1.cochrane.org\/\n                    \n                  ; 2011."},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1745-6215-10-46","volume":"10","author":"T Wu","year":"2009","unstructured":"Wu T, Li Y, Bian Z, Liu G, Moher D. Randomized trials published in some Chinese journals: how many are randomized? Trials. 2009;10:46.","journal-title":"Trials"},{"issue":"1","key":"554_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jclinepi.2010.02.010","volume":"64","author":"D Zhang","year":"2011","unstructured":"Zhang D, Freemantle N, Cheng KK. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol. 2011;64(1):90\u20135.","journal-title":"J Clin Epidemiol"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1745-6215-9-22","volume":"9","author":"D Zhang","year":"2008","unstructured":"Zhang D, Yin P, Freemantle N, Jordan R, Zhong N, Cheng KK. An assessment of the quality of randomised controlled trials conducted in China. Trials. 2008;9:22.","journal-title":"Trials"},{"issue":"2","key":"554_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/JCP.0b013e31820f932a","volume":"31","author":"M Koesters","year":"2011","unstructured":"Koesters M, Zhang Y, Ma YC, Weinmann S, Becker T, Jin WD. What can we learn from Chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies. J Clin Psychopharmacol. 2011;31(2):194\u2013200.","journal-title":"J Clin Psychopharmacol"},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"i5396","DOI":"10.1136\/bmj.i5396","volume":"355","author":"M Woodhead","year":"2016","unstructured":"Woodhead M. 80% of China's clinical trial data are fraudulent, investigation finds. BMJ. 2016;355:i5396.","journal-title":"BMJ"},{"issue":"7278","key":"554_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/463142a","volume":"463","author":"J Qiu","year":"2010","unstructured":"Qiu J. Publish or perish in China. Nature. 2010;463(7278):142\u20133.","journal-title":"Nature"},{"issue":"6350","key":"554_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1126\/science.357.6350.435","volume":"357","author":"D Normile","year":"2017","unstructured":"Normile D. China cracks down on fraud. Science. 2017;357(6350):435.","journal-title":"Science"},{"issue":"4","key":"554_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jebm.12173","volume":"8","author":"XT Liu","year":"2015","unstructured":"Liu XT, Zhang X, Wen S, Peng L, Hong Q, Kang D. Impact of the consolidated standards of reporting trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine. J Evid Based Med. 2015;8(4):192\u2013208.","journal-title":"J Evid Based Med"},{"issue":"1","key":"554_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11655-016-2451-z","volume":"23","author":"LM Lu","year":"2017","unstructured":"Lu LM, He J, Zeng JC, Liao MX, Jia C, Pan HH. Impact evaluation of CONSORT and STRICTA guidelines on reporting quality for randomized controlled trials of acupuncture conducted in China. Chin J Integr Med. 2017;23(1):10\u20137.","journal-title":"Chin J Integr Med"},{"issue":"1","key":"554_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1471-1842.2007.00734.x","volume":"25","author":"J Xia","year":"2008","unstructured":"Xia J, Wright J, Adams CE. Five large Chinese biomedical bibliographic databases: accessibility and coverage. Health Inf Libr J. 2008;25(1):55\u201361.","journal-title":"Health Inf Libr J"},{"issue":"1","key":"554_CR19","first-page":"9","volume":"37","author":"M Wang","year":"2013","unstructured":"Wang M, Zhou Z, Fang H, Liu X. The bibliometric characteristics of Chinese medical core journals. Ser Rev. 2013;37(1):9\u201313.","journal-title":"Ser Rev"},{"key":"554_CR20","unstructured":"JMP\u00ae, Version <12.2.0>. SAS Institute Inc., Cary, NC, 1989\u20132007."},{"issue":"3","key":"554_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jebm.12268","volume":"10","author":"T Wu","year":"2017","unstructured":"Wu T, Bian Z, Shang H, Li Y. Innovation of clinical trials in China: commentary on the publication of \u201cCONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration\u201d. J Evid Based Med. 2017;10(3):155\u201362.","journal-title":"J Evid Based Med"},{"key":"554_CR22","unstructured":"Liao J, Bi S: Clinical studies should be prospective: an interview to biomedical statistical expert professor Hu Lianping (\u5ed6\u6770, \u78a7\u77f3. \u4e34\u5e8a\u7814\u7a76\u8981\u6709\u524d\u77bb\u6027\u2014\u2014\u8bbf\u751f\u7269\u7edf\u8ba1\u5b66\u4e13\u5bb6\u80e1\u826f\u5e73\u6559\u6388. \u4e2d\u56fd\u533b\u5b66\u8bba\u575b\u62a5). China Medical Tribune 2005."},{"issue":"5\u20136","key":"554_CR23","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1080\/08989621.2013.822248","volume":"20","author":"JM DuBois","year":"2013","unstructured":"DuBois JM, Anderson EE, Chibnall J, Carroll K, Gibb T, Ogbuka C, Rubbelke T. Understanding research misconduct: a comparative analysis of 120 cases of professional wrongdoing. Account Res. 2013;20(5\u20136):320\u201338.","journal-title":"Account Res"},{"issue":"5","key":"554_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005738","volume":"4","author":"D Fanelli","year":"2009","unstructured":"Fanelli D. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One. 2009;4(5):e5738.","journal-title":"PLoS One"},{"key":"554_CR25","doi-asserted-by":"crossref","unstructured":"A consensus statement on research misconduct in the UK. BMJ 2012, 344:e1111.","DOI":"10.1136\/bmj.e1111"},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"j1879","DOI":"10.1136\/bmj.j1879","volume":"357","author":"M McCarthy","year":"2017","unstructured":"McCarthy M. Independent board needed to promote research integrity, US panel says. BMJ. 2017;357:j1879.","journal-title":"BMJ"},{"issue":"23","key":"554_CR27","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1212\/WNL.0000000000003387","volume":"87","author":"MJ Bolland","year":"2016","unstructured":"Bolland MJ, Avenell A, Gamble GD, Grey A. Systematic review and statistical analysis of the integrity of 33 randomized controlled trials. Neurology. 2016;87(23):2391\u2013402.","journal-title":"Neurology"},{"issue":"5","key":"554_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2044.2012.07128.x","volume":"67","author":"JB Carlisle","year":"2012","unstructured":"Carlisle JB. The analysis of 168 randomised controlled trials to test data integrity. Anaesthesia. 2012;67(5):521\u201337.","journal-title":"Anaesthesia"},{"issue":"9074","key":"554_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","volume":"350","author":"M Egger","year":"1997","unstructured":"Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350(9074):326\u20139.","journal-title":"Lancet"},{"issue":"1","key":"554_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2288-2-6","volume":"2","author":"TA Furukawa","year":"2002","unstructured":"Furukawa TA, Inada T, Adams CE, McGuire H, Inagaki A, Nozaki S. Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials. BMC Med Res Methodol. 2002;2(1):6.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"554_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13063-015-0769-z","volume":"16","author":"TJ Song","year":"2015","unstructured":"Song TJ, Leng HF, Zhong LL, Wu TX, Bian ZX. CONSORT in China: past development and future direction. Trials. 2015;16:243.","journal-title":"Trials"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.","journal-title":"BMJ"},{"key":"554_CR34","doi-asserted-by":"crossref","unstructured":"Reforming research in China. Lancet 2007, 369(9565):880.","DOI":"10.1016\/S0140-6736(07)60419-X"},{"issue":"9716","key":"554_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0140-6736(10)60288-7","volume":"375","author":"L Guo","year":"2010","unstructured":"Guo L. China boosts medical research. Lancet. 2010;375(9716):711.","journal-title":"Lancet"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12874-018-0554-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:53:33Z","timestamp":1589453613000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-018-0554-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1186\/s12874-018-0554-2","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the ethics committee of Kyoto University Graduate School of Medicine (registration number R1019). All participants provided oral consent over the telephone, as per the ethics committee\u2019s approval, during the telephone interview after full disclosure of the purpose and methods of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TAF has received lecture fees from Janssen, Meiji, Mitsubishi-Tanabe, MSD and Pfizer and research support from Mitsubishi-Tanabe and Mochida, all outside the submitted work. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"96"}}